
CRISPR Therapeutics (CRSP) Earnings Dates & Reports
CRISPR Therapeutics (CRSP) Most Recent Earnings
Report DateAug 4, 2025
Period EndingQ2 2025
Est. EPS-$1.43
Actual EPS-$1.29
EarningsBeat
CRISPR Therapeutics (CRSP) Earnings
View the latest CRISPR Therapeutics (CRSP) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in CRISPR Therapeutics (CRSP)
Order type
Buy in
Order amount
Est. shares
0 shares
CRISPR Therapeutics (CRSP) Earnings per Share (EPS) History
Signup for full accessBrowse free
CRISPR Therapeutics (CRSP) Latest Earnings
The value each CRSP share was expected to gain vs. the value each share gained.
CRISPR Therapeutics (CRSP) reported its most recent earnings on Aug 4, 2025 for Q2 2025, posting earnings per share (EPS) of -$1.29. This exceeded analysts' expectations of -$1.43 by 9.79%, marking a Beat.
For comparison, CRISPR Therapeutics reported EPS of -$1.49 in the same quarter last year.
The company is expected to announce its next earnings report on 11/04/2025, with analysts projecting an EPS of -$1.31.
CRISPR Therapeutics (CRSP) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 4, 2025 | -$1.31 | Next earnings call Nov. 4, 2025 | ||
Q2 2025Aug 4, 2025 | -$1.43 | -$1.29 | -9.79% | |
Q1 2025May 6, 2025 | -$1.25 | -$1.58 | +26.40% | |
Q4 2024Feb 11, 2025 | -$1.21 | -$0.44 | -63.64% | |
Q3 2024Nov 5, 2024 | -$1.42 | -$1.01 | -28.87% | |
CRISPR Therapeutics (CRSP) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the CRISPR Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 4, 2025 | — | — | — |
May 6, 2025 | — | — | — |
Feb 11, 2025 | — | — | — |
Nov 5, 2024 | — | — | — |
CRISPR Therapeutics (CRSP) Earnings FAQs
CRISPR Therapeutics (CRSP) last reported earnings on Aug 4, 2025 for Q2 2025, posting an EPS of -$1.29, which Beat the estimate of -$1.43 by 9.79%.
For Q2 2025, CRISPR Therapeutics (CRSP) reported an EPS of -$1.29, exceeding analysts' estimate of -$1.43 by 9.79%.
For Q2 2025, CRISPR Therapeutics (CRSP) Beat expectations with an actual EPS of -$1.29 vs. an estimated EPS of -$1.43.
Following the last earnings report on Aug 4, 2025, CRISPR Therapeutics (CRSP)'s stock price moved — from — to —.
The next CRISPR Therapeutics (CRSP) earnings call is scheduled for Nov. 4, 2025, where executives will discuss financial results and outlook.